Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 1113-1121

  Hudson, Tamaro S ^a,g   Perkins, Susan N ^b   Hursting, Stephen D ^b,c   Young, Heather A ^d   Kim, Young S ^a   Wang, Tien Chung ^e   Wang, Thomas T Y ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b The University of Texas at Austin   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^g HOWARD UNIVERSITY CANCER CENTER   (United States)

Author keywords

Angiogenesis; Phenethyl isothiocyanate; Prevention; Prostate cancer; Xenograft

Indexed keywords

ALPHA2 INTEGRIN; ALPHA6 INTEGRIN; ANDROGEN RECEPTOR; BETA1 INTEGRIN; CD31 ANTIGEN; CELL MARKER; MESSENGER RNA; PHENETHYL ISOTHIOCYANATE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; DIETARY INTAKE; GENE EXPRESSION; HORMONE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; CELL GROWTH PROCESSES; CELL-MATRIX JUNCTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOTHIOCYANATES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863371275     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1335     Document Type: Article

References (39)

1. Ozasa K, Nakao M, Watanabe Y, Hayashi K, et al: Serum phyto-estrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95: 65-71, 2004. (Pubitemid 38208409)
2. Boyle P, Levi F, Lucchini F, La Vecchia C, et al: Trends in diet-related cancers in Japan: a conundrum? Lancet 342: 752, 1993. (Pubitemid 23279791)
3. Morton MS, Griffiths K and Blacklock N: The preventive role of diet in prostatic disease. Br J Urol 77: 481-493, 1996. (Pubitemid 26130736)
4. Cook LS, Goldoft M, Schwartz SM and Weiss NS: Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 161: 152-155, 1999. (Pubitemid 29422310)
5. Stellman SD and Wang QS: Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites. Cancer 73: 1270-1275, 1994. (Pubitemid 24061626)
6. Schuman LM and Mandel JS: Epidemiology of prostatic cancer in blacks. Prev Med 9: 630-649, 1980. (Pubitemid 10019194)
7. Whittemore AS, Lele C, Friedman GD, Stamey T, et al: Prostate-specific antigen as predictor of prostate cancer in black men and white men. J Natl Cancer Inst 87: 354-360, 1995.
8. Singh RP and Agarwal R: Tumor angiogenesis: a potential target in cancer control by phytochemicals. Curr Cancer Drug Targets 3: 205-217, 2003. (Pubitemid 36565762)
9. Zarkovic N, Vukovic T, Loncaric I, Miletic M, et al: An overview on anticancer activities of the Viscum album extract Isorel. Cancer Biother Radiopharm 16: 55-62, 2001. (Pubitemid 32231717)
10. Hecht SS: Chemoprevention by isothiocyanates. J Cell Biochem 22 (Suppl): 195-209, 1995.
11. Zhang Y, Kensler TW, Cho CG, Posner GH and Talalay P: Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 91: 3147-3150, 1994. (Pubitemid 24130192)
12. Yu R, Mandlekar S, Harvey KJ, Ucker DS and Kong AN: Chemo-preventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res 58: 402-408, 1998. (Pubitemid 28087397)
13. Xu K and Thornalley PJ: Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro. Biochem Pharmacol 61: 165-177, 2001. (Pubitemid 32121781)
14. Xiao D and Singh SV: Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 62: 3615-3619, 2002. (Pubitemid 34728834)
15. Xu C, Shen G, Chen C, Gelinas C and Kong AN: Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24: 4486-4495, 2005. (Pubitemid 41032612)
16. Xiao D and Singh SV: Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res 67: 2239-2246, 2007. (Pubitemid 46424243)
17. Morse MA, Reinhardt JC, Amin SG, Hecht SS, et al: Effect of dietary aromatic isothiocyanates fed subsequent to the administration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumorigenicity in mice. Cancer Lett 49: 225-230, 1990. (Pubitemid 20100949)
18. Zhou JR, Gugger ET, Tanaka T, Guo Y, et al: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129: 628-1635, 1999.
19. Wang TT, Hudson TS, Wang TC, Remsberg CM, et al: Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 29: 2001-2010, 2008.
20. Hunter AL, Choy JC and Granville DJ: Detection of apoptosis in cardiovascular diseases. Methods Mol Med 112: 277-289, 2005.
21. Cher ML, Chew K, Rosenau W and Carroll PR: Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Prostate 26: 87-93, 1995.
22. Takahashi Y, Lavigne JA, Hursting SD, Chandramouli GV, et al: Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray. Mol Carcinog 45: 943-956, 2006. (Pubitemid 44907384)
23. Goel HL, Alam N, Johnson IN and Languino LR: Integrin signaling aberrations in prostate cancer. Am J Transl Res 1: 211-220, 2009.
24. Kim JH, Xu C, Keum YS, Reddy B, et al: Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27: 475-482, 2006. (Pubitemid 43372876)
25. Xiao D, Johnson CS, Trump DL and Singh SV: Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells. Mol Cancer Ther 3: 567-575, 2004. (Pubitemid 39193735)
26. Chen YR, Han J, Kori R, Kong AN and Tan TH: Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase. J Biol Chem 277: 39334-39342, 2002. (Pubitemid 35190906)
27. Xiao D, Herman-Antosiewicz A, Antosiewicz J, Xiao H, et al: Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc 25 C. Oncogene 24: 6256-6268, 2005. (Pubitemid 43080049)
28. Van Moorselaar RJ and Voest EE: Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol 197: 239-250, 2002. (Pubitemid 35304798)
29. Weidner N, Carroll PR, Flax J, Blumenfeld W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993. (Pubitemid 24058195)
30. Cao G, O'Brien CD, Zhou Z, Sanders SM, et al: Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol 282: C1181-C1190, 2002. (Pubitemid 34663126)
31. Zeng ZZ, Jia Y, Hahn NJ, Markwart SM, Rockwood KF and Livant DL: Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res 66: 8091-8099, 2006. (Pubitemid 44299175)
32. Hall CL, Dubyk CW, Riesenberger TA, Shein D, Keller ET and van Golen KL: Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase. Neoplasia 10: 797-803, 2008.
33. Sroka IC, Anderson TA, McDaniel KM, Nagle RB, Gretzer MB and Cress AE: The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion. J Cell Physiol 224: 283-288, 2010.
34. Morse MA, Zu H, Galati AJ, Schmidt CJ and Stoner GD: Dose-related inhibition by dietary phenethyl isothiocyanate of esophageal tumorigenesis and DNA methylation induced by N-nitrosomethylbenzylamine in rats. Cancer Lett 72: 103-110, 1993. (Pubitemid 23273688)
35. Stoner GD, Morrissey DT, Heur YH, Daniel EM, et al: Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res 51: 2063-2068, 1991.
36. Wattenberg LW: Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure. Cancer Res 41: 2991-2994, 1981.
37. Wattenberg LW: Inhibitory effects of benzyl isothiocyanate administered shortly before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice. Carcinogenesis 8: 1971-1973, 1987.
38. Hsu JC, Zhang J, Dev A, Wing A, et al: Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells. Carcinogenesis 26: 1896-1904, 2005. (Pubitemid 41631262)
39. Talalay P and Fahey JW: Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131: S3027-S3033, 2001.